PMID: 15226466Jul 1, 2004Paper

Modest protective effects of isoflavones from a red clover-derived dietary supplement on cardiovascular disease risk factors in perimenopausal women, and evidence of an interaction with ApoE genotype in 49-65 year-old women

The Journal of Nutrition
Charlotte AtkinsonSheila A Bingham

Abstract

Data suggest that soy protein, a source of isoflavones, may have favorable effects on cardiovascular risk factors. Women (n = 205), ages 49-65 y, were randomized into this double blind, placebo-controlled trial of 43.5 mg red clover-derived isoflavones/d. A total of 177 women completed the trial. There were no differences between treatments for changes from baseline to 12 mo in total cholesterol, LDL cholesterol, triglycerides, HDL cholesterol, systolic and diastolic blood pressures, fibrinogen, and plasminogen activator inhibitor type 1 (PAI-1) (P >/= 0.1). Interactions between treatment and menopausal status were significant for changes in triglycerides and PAI-1 (P = 0.02 and P = 0.01), and changes were significant among perimenopausal women. In the isoflavone and placebo groups, changes in triglycerides were -0.2 +/- 0.6 and 0.4 +/- 0.6 mmol/L, P = 0.02, and changes in PAI-1 were -3.06 +/- 5.88 and 4.95 +/- 6.25 IU/L, P = 0.004, respectively. Interactions between apolipoprotein E (apoE) genotype and treatment tended to be significant for changes in total and LDL cholesterol (P = 0.06 and P = 0.05), and differences between treatments were significant in E2/E3 women. In the isoflavone and placebo groups, changes in total chol...Continue Reading

References

Jun 1, 1976·AJR. American Journal of Roentgenology·J N Wolfe
Aug 3, 1995·The New England Journal of Medicine·J W AndersonM E Cook-Newell
Jan 15, 1995·Circulation·M Dammerman, J L Breslow
Jan 1, 1995·Proceedings of the Society for Experimental Biology and Medicine·A A FrankeK Narala
Jun 15, 1993·Annals of Internal Medicine·E Ernst, K L Resch
Jan 1, 1996·Nutrition and Cancer·K Reinli, G Block
Dec 1, 1996·Obstetrics and Gynecology·F BruschiP G Crosignani
Dec 31, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·M S AnthonyJ D Wagner
Feb 12, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·A M HeikkinenS Saarikoski
Jun 1, 2000·The American Journal of Cardiology·L A SimonsD S Celermajer
Jun 6, 2000·The American Journal of Clinical Nutrition·B E Merz-DemlowM S Kurzer
Jun 15, 2000·The New England Journal of Medicine·H P Kohler, P J Grant
Sep 12, 2000·Current Cardiology Reports·W Koenig
Feb 24, 2001·Journal of the American College of Nutrition·E L AshtonM J Ball
Jul 13, 2001·Menopause : the Journal of the North American Menopause Society·P B Clifton-BlighT Moreton
Sep 28, 2001·Current Opinion in Cardiology·J S Forrester
Nov 10, 2001·Annual Review of Genomics and Human Genetics·R W Mahley, S C Rall
Jan 15, 2002·The Journal of Clinical Endocrinology and Metabolism·Antonella DewellBonnie Bruce
Jun 27, 2002·The American Journal of Cardiology·Robert H Knopp
Jul 5, 2002·The Journal of Nutrition·Miguel RivasJosé O Alda
Oct 16, 2002·Current Cardiology Reports·John E Hokanson
Jan 30, 2004·The American Journal of Clinical Nutrition·Charlotte AtkinsonSheila A Bingham

❮ Previous
Next ❯

Citations

Jul 14, 2005·Annual Review of Nutrition·Dolores Corella, Jose M Ordovas
Jun 1, 2005·Nutrition Research Reviews·Wendy L HallChristine M Williams
Jul 1, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Mi Ran KimYoung Chul Lee
Apr 29, 2006·Menopause : the Journal of the North American Menopause Society·Nancy L BoothNorman R Farnsworth
Jan 15, 2005·Current Opinion in Lipidology·Lindsey F Masson, Geraldine McNeill
Nov 16, 2012·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J W Nieves
Jan 31, 2006·The Proceedings of the Nutrition Society·Aedin CassidyFrancesco Branca
May 9, 2012·The Proceedings of the Nutrition Society·Sarah EgertPatricia Huebbe
Dec 27, 2007·Journal of Medicinal Food·Won O SongSung G Lee
Oct 3, 2018·Climacteric : the Journal of the International Menopause Society·Â LuísL Pereira
Nov 26, 2008·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Peter ChedrauiSusana Ross
Sep 24, 2009·Molecular Nutrition & Food Research·Alicja MortensenGerhard Sontag
Jun 8, 2013·The Cochrane Database of Systematic Reviews·Yu QinMan Tian Mi
Jul 13, 2021·Critical Reviews in Food Science and Nutrition·Saied A AboushanabElena G Kovaleva
Sep 30, 2009·The American Journal of Medicine·Clemens B TempferJohannes C Huber
Sep 15, 2010·Fitoterapia·May Fern Toh, Joanna E Burdette

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.